tirzepatide 2.5 mg/0.5 ml pnij Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Tirzepatide's Association With BP Reduction

Animal studies showed C-cell tumors in rodents

[1] In adults with confirmed GH deficiency, sermorelin may also be considered as a treatment option, although its use in healthy older adults for anti-aging purposes remains unproven and is not an FDA-approved indication

Eli Lilly, the maker of Zepbound and Mounjaro, is also taking a firm stance

The exact number depends on skin type, tone, and lifestyle factors such as sun exposure and diet

Our team helps clients assess risk and make informed decisions grounded in current law and enforcement trends

Ideally, wed lose weight without needing medications through changes in our diet and lifestyle